MDS Abstracts

Abstracts from the International Congress of Parkinson’s and Movement Disorders.

MENU 
  • Home
  • Meetings Archive
    • 2024 International Congress
    • 2023 International Congress
    • 2022 International Congress
    • MDS Virtual Congress 2021
    • MDS Virtual Congress 2020
    • 2019 International Congress
    • 2018 International Congress
    • 2017 International Congress
    • 2016 International Congress
  • Keyword Index
  • Resources
  • Advanced Search
  • MDS Virtual Congress 2021

    The volume of STN tissue activated by DBS and the strength of its structural connectivity with SMA predicts the effects of STN-DBS on response inhibition

    G. Meyer, M. Albares, S. Thobois, E. Broussolle, G. Polo, P. Baraduc, B. Ballanger, ML. Welter, B. Lau, P. Boulinguez (Bron, France)

    Objective: To test the hypothesis that antidromic activation of the hyperdirect pathway might mediate the effects of STN-DBS on movement initiation control. Background: In PD,…
  • MDS Virtual Congress 2021

    Alterations in brain functional network connectivity in Parkinson’s disease patients with MCI

    K. Sreenivasan, X. Zhuang, J. Caldwell, A. Ritter, D. Cordes, Z. Mari, V. Mishra (Las Vegas, USA)

    Objective: To investigate functional network abnormalities in Parkinson’s disease patients with mild cognitive impairment (PD-MCI) and PD patients who are cognitively normal (PD-NC). Background: Cognitive…
  • MDS Virtual Congress 2021

    The Commercial Genetic Testing Landscape for Parkinson’s Disease

    L. Cook, J. Schulze, J. Verbrugge, C. Klein, A. Naito, R. Alcalay (Indianapolis, USA)

    Objective: To evaluate commercial genetic testing offered for Parkinson’s disease (PD) Background: The etiology of PD is complex and, typically, multifactorial. At least 6 genes…
  • MDS Virtual Congress 2021

    GBA variants in a multi-ethnic Parkinson’s disease (PD) cohort in Malaysia

    JL. Lim, K. Lohmann, AH. Tan, YW. Tay, KA. Ibrahim, Z. Abdul Aziz, AS. Mawardi, S. Datuk Puvanarajah, I. Looi, YK. Chia, TT. Lim, P. Bauer, A. Rolfs, C. Klein, A. Ahmad-Annuar, S-Y. Lim (Kuala Lumpur, Malaysia)

    Objective: To investigate the frequency of Glucocerebrosidase (GBA) gene variants in a multi-ethnic Parkinson’s disease (PD) cohort in Malaysia. Background: GBA variants have been associated…
  • MDS Virtual Congress 2021

    Lack of diversity in Parkinson’s disease genetic research: current landscape and future directions

    A. Schumacher-Schuh, A. Bieger, M. Strelow, O. Okunoye, K. Mok, A. Ahmad-Annuar, S. Bardien, S-Y. Lim, S. Rao, Y. Zewde, S. Dindayal, J. Azar, S. Lesage, I. Mata, GP2. Genetics Project (Porto Alegre, Brazil)

    Objective: We conducted a systematic review to summarize past studies on Parkinson's disease (PD) genetics research among underrepresented populations (URP), defined as being non-European ancestry. We…
  • MDS Virtual Congress 2021

    Silencing of hypoxia-inducible factor 1 alpha provokes a neuroprotective response in a SH-SY5Y model of Parkinson’s Disease.

    S. Acharya, A. Lumley, C. Mebarki, V. Stopa, M. Vausort, Y. Devaux (Strassen, Luxembourg)

    Objective: Our study aims to delineate the role of HIF1α in a SH-SY5Y model of Parkinson’s disease (PD) Background: Parkinson’s disease (PD) is one of…
  • MDS Virtual Congress 2021

    Next-generation sequencing of plasma-associated extracellular vesicle miRNAs as potential biomarkers for Parkinson’s disease and its prodromal stage

    L. Li, L. Liu (Shanghai, China)

    Objective: This study aimed to identify subsets of plasma EV-associated miRNAs with diagnostic potential for PD and iRBD, the prodromal stage of PD. Background: Parkinson’s…
  • MDS Virtual Congress 2021

    Metabolic alterations in a Drosophila model of Parkinson’s disease

    C. Solana-Manrique, F J. Sanz, I. Torregrosa, N. Paricio (Burjassot, Spain)

    Objective: Identification of metabolic alterations that could be contributing to Parkinson’s disease (PD) physiopathology and become new biomarkers or therapeutic targets for the disease. Background:…
  • MDS Virtual Congress 2021

    Distinct memory networks in Parkinson’s disease (PD) and Alzheimer’s disease (AD): Effects of APOE

    G. Coughlan, P. Mclaughlin, K. Sunderland, M. Borrie, C. Fischer, A. Frank, M. Freedman, S. Kumar, S. Pasternak, B. Pollock, T. Rajji, D. Seitz, D. Tang-Wai, C. Tartaglia, J. Dewar, D. Kwan, B. Tan, D. Grimes, M. Jog, T. Lang, C. Marras, T. Steeves, D. Bulman, A. Dilliott, M. Ghani, R. Hegele, J. Robinson, E. Rogaeva, S. Farhan, R. Bartha, N. Nanayakkara, J. Ramirez, C. Scott, S. Symons, C. Berezuk, M. Holmes, S. Adamo, M. Ozzoude, A. Theyers, S. Arnott, D. Beaton, W. Lou, S. Sujanthan, B. Levine, J. Orange, A. Peltsch, A. Roberts, A. Troyer, M. Binns, S. Black, S. Strother, M. Moscovitch, C. Grady, M. Masellis (Toronto, Canada)

    Objective: As part of the Ontario Neurodegenerative Disease Research Initiative, we investigated group differences in functional connectivity within two distinct memory networks: posterior medial network…
  • MDS Virtual Congress 2021

    Striatal dopaminergic loss in early clinically unilateral Parkinson’s disease: a systematic review

    N. Heng, N. Malek, M. Lawton, K. Grosset, Y. Ben-Shlomo, D. Grosset (Glasgow, United Kingdom)

    Objective: To quantify the extent of dopaminergic loss in early clinically unilateral PD from studies using presynaptic dopamine imaging with either single photon emission computed tomography…
  • « Previous Page
  • 1
  • …
  • 77
  • 78
  • 79
  • 80
  • 81
  • …
  • 132
  • Next Page »

Most Viewed Abstracts

  • This Week
  • This Month
  • All Time
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
  • An atypical and interesting feature of Parkinson´s disease
  • Covid vaccine induced parkinsonism and cognitive dysfunction
  • Life expectancy with and without Parkinson’s disease in the general population
  • What is the appropriate sleep position for Parkinson's disease patients with orthostatic hypotension in the morning?
  • An atypical and interesting feature of Parkinson´s disease
  • Estimation of the 2020 Global Population of Parkinson’s Disease (PD)
    • Help & Support
    • About Us
    • Cookies & Privacy
    • Wiley Job Network
    • Terms & Conditions
    • Advertisers & Agents
    Copyright © 2025 International Parkinson and Movement Disorder Society. All Rights Reserved.
    Wiley